ArticleGeroScience2021

Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary.

Balint Gergely Szabo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.